Fourth Quarter Sales of
Continued Focus on Simplification Strategy to
Apparel Sales in the Outdoor segment up 10% in the Fourth Quarter
Fourth Quarter 2025 Financial Summary vs. Same Year-Ago Quarter
- Sales of
$65.4 million compared to$71.4 million . - Gross margin was 27.7% compared to 33.4%; adjusted gross margin of 33.6% compared to 38.0%.
- Net loss of
$31.3 million , or$(0.81) per diluted share1, compared to net loss(including the impact of discontinued operations) of$65.5 million , or$(1.71) per diluted share2. - Loss from continuing operations of
$31.3 million , or$(0.81) per diluted share, compared to loss from continuing operations of$73.3 million , or$(1.92) per diluted share. - Adjusted net income of
$3.6 million , or$0.09 per diluted share, compared to adjusted net loss of$3.2 million , or$(0.08) per diluted share. - Adjusted EBITDA of
$1.2 million with an adjusted EBITDA margin of 1.8% compared to$4.4 million with an adjusted EBITDA margin of 6.1%.
2025 Financial Summary vs. 2024
- Sales of
$250.4 million compared to$264.3 million . - Gross margin was 33.1% compared to 35.0%; adjusted gross margin was 34.9% compared to 37.5%.
- Net loss of
$46.6 million , or$(1.21) per diluted share1, compared to net loss (including the impact of discontinued operations)of$52.3 million , or$(1.37) per diluted share3. - Loss from continuing operations of
$46.6 million , or$(1.21) per diluted share, compared to loss from continuing operations of$88.4 million , or$(2.31) per diluted share. - Adjusted income from continuing operations of
$3.7 million , or$0.10 per diluted share, compared to adjusted loss from continuing operations of$2.6 million , or$(0.07) per diluted share. - Adjusted EBITDA of
$1.1 million with an adjusted EBITDA margin of 0.4% compared to$6.9 million with an adjusted EBITDA margin of 2.6%.
1 Includes
2 Includes
3 Includes a gain on the sale of the Precision Sport segment of
Management Commentary
“We took decisive actions in 2025 to sharpen our focus and position Clarus for category-specific growth and greater profitability,” said
Fourth Quarter 2025 Financial Results
Sales in the fourth quarter were
The decrease in Outdoor sales was due to softness in
The decrease in sales in the Adventure segment reflects significantly reduced demand from global OEM customers and a challenging wholesale market in
Gross margin in the fourth quarter was 27.7% compared to 33.4% in the year-ago quarter. The decrease in gross margin was primarily due to higher inventory reserves within the Adventure segment to address slow-moving and obsolete inventory, tariff impacts at both segments, lower volumes at the Outdoor segment due to the sale of PIEPS, and unfavorable foreign currency impacts at the Outdoor segment. These decreases were partially offset by a favorable product mix and lower PFAS inventory reserves at the Outdoor segment. Adjusted gross margin, reflecting the PFAS related and other inventory reserves and inventory fair value adjustments as a result of purchase accounting, was 33.6% for the quarter compared to 38.0% in the year-ago quarter.
Selling, general and administrative expenses in the fourth quarter were
During the fourth quarter of 2025, the Company incurred non-cash impairment charges for goodwill and indefinite-lived assets of
The loss from continuing operations in the fourth quarter of 2025 was
Adjusted net income in the fourth quarter of 2025 was
Adjusted EBITDA in the fourth quarter was
Net cash provided by operating activities for the three months ended
Liquidity at
- Cash and cash equivalents totaled
$36.7 million compared to$45.4 million . - Total debt of
$0.0 million compared to$1.9 million .
Full Year 2025 Financial Results
Sales in 2025 decreased 5.2% to
From a segment perspective, Outdoor sales were down
Gross margin in 2025 was 33.1% compared to 35.0% in 2024 primarily due to lower volumes at the Outdoor and Adventure segments, impacts due to tariffs imposed by
Selling, general and administrative expenses in 2025 were
Loss from continuing operations in 2025 was
Adjusted income from continuing operations in 2025 was
Adjusted EBITDA in 2025 was
Net cash used in operating activities for the year ended
2026 Outlook
The Company expects fiscal year 2026 sales to range between
Net Operating Loss (NOL) and Deferred Tax Asset Valuation Allowance
As of
Conference Call
The Company will hold a conference call today at
Date:
Time:
Registration Link: https://register-conf.media-server.com/register/BI94bda81119fd427295496ddd3b0b57f4
To access the call by phone, please register via the live call registration link above and you will be provided with dial-in instructions and details. The conference call will be broadcast live and available for replay here and on the Company’s website at www.claruscorp.com.
About
Headquartered in
Use of Non-GAAP Measures
The Company reports its financial results in accordance with
Forward-Looking Statements
Please note that in this press release we may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this press release, include, but are not limited to, those risks and uncertainties more fully described from time to time in the Company's public reports filed with the Securities and Exchange Commission, including under the section titled “Risk Factors” in the Company's Annual Report on Form 10-K, and/or Quarterly Reports on Form 10-Q, as well as in the Company’s Current Reports on Form 8-
Company Contact:
Chief Financial Officer
mike.yates@claruscorp.com
Investor Relations:
Tel 1-212-477-8438 / 1-212-227-7098
lberman@igbir.com / mberkowitz@igbir.com
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
| (Unaudited) | |||||||
| (In thousands, except per share amounts) | |||||||
| Assets | |||||||
| Current assets | |||||||
| Cash | $ | 36,691 | $ | 45,359 | |||
| Accounts receivable, net | 44,839 | 43,678 | |||||
| Inventories | 83,028 | 82,278 | |||||
| Prepaid and other current assets | 5,457 | 5,555 | |||||
| Income tax receivable | 1,407 | 910 | |||||
| Total current assets | 171,422 | 177,780 | |||||
| Property and equipment, net | 18,255 | 17,606 | |||||
| Other intangible assets, net | 23,761 | 31,516 | |||||
| Indefinite-lived intangible assets | 19,600 | 46,750 | |||||
| - | 3,804 | ||||||
| Deferred income taxes | 55 | 36 | |||||
| Other long-term assets | 15,935 | 16,602 | |||||
| Total assets | $ | 249,028 | $ | 294,094 | |||
| Liabilities and Stockholders’ Equity | |||||||
| Current liabilities | |||||||
| Accounts payable | $ | 15,907 | $ | 11,873 | |||
| Accrued liabilities | 24,403 | 22,276 | |||||
| Income tax payable | 179 | - | |||||
| Current portion of long-term debt | - | 1,888 | |||||
| Total current liabilities | 40,489 | 36,037 | |||||
| Deferred income taxes | 1,418 | 12,210 | |||||
| Other long-term liabilities | 10,728 | 12,754 | |||||
| Total liabilities | 52,635 | 61,001 | |||||
| Stockholders’ Equity | |||||||
| Preferred stock, | - | - | |||||
| Common stock, | 4 | 4 | |||||
| Additional paid in capital | 703,487 | 697,592 | |||||
| Accumulated deficit | (457,253 | ) | (406,857 | ) | |||
| (33,156 | ) | (33,114 | ) | ||||
| Accumulated other comprehensive loss | (16,689 | ) | (24,532 | ) | |||
| Total stockholders’ equity | 196,393 | 233,093 | |||||
| Total liabilities and stockholders’ equity | $ | 249,028 | $ | 294,094 | |||
| CONDENSED CONSOLIDATED STATEMENTS OF LOSS | |||||||
| (Unaudited) | |||||||
| (In thousands, except per share amounts) | |||||||
| Three Months Ended | |||||||
| Sales | |||||||
| Domestic sales | $ | 28,329 | $ | 30,162 | |||
| International sales | 37,084 | 41,243 | |||||
| Total sales | 65,413 | 71,405 | |||||
| Cost of goods sold | 47,277 | 47,540 | |||||
| Gross profit | 18,136 | 23,865 | |||||
| Operating expenses | |||||||
| Selling, general and administrative | 25,492 | 27,772 | |||||
| Restructuring charges | 478 | 939 | |||||
| Transaction costs | 66 | 408 | |||||
| Legal costs and regulatory matter expenses | 1,219 | 47 | |||||
| Impairment of goodwill | 3,804 | 36,264 | |||||
| Impairment of indefinite-lived intangible assets | 26,069 | 8,545 | |||||
| Total operating expenses | 57,128 | 73,975 | |||||
| Operating loss | (38,992 | ) | (50,110 | ) | |||
| Other income (expense) | |||||||
| Interest income, net | 101 | 269 | |||||
| Other, net | 974 | (2,342 | ) | ||||
| Total other income (expense), net | 1,075 | (2,073 | ) | ||||
| Loss before income tax | (37,917 | ) | (52,183 | ) | |||
| Income tax (benefit) expense | (6,656 | ) | 21,142 | ||||
| Loss from continuing operations | (31,261 | ) | (73,325 | ) | |||
| Discontinued operations, net of tax | - | 7,804 | |||||
| Net loss | $ | (31,261 | ) | $ | (65,521 | ) | |
| Loss from continuing operations per share: | |||||||
| Basic | $ | (0.81 | ) | $ | (1.92 | ) | |
| Diluted | (0.81 | ) | (1.92 | ) | |||
| Net loss per share: | |||||||
| Basic | $ | (0.81 | ) | $ | (1.71 | ) | |
| Diluted | (0.81 | ) | (1.71 | ) | |||
| Weighted average shares outstanding: | |||||||
| Basic | 38,402 | 38,262 | |||||
| Diluted | 38,402 | 38,262 | |||||
| CONDENSED CONSOLIDATED STATEMENTS OF LOSS | |||||||
| (Unaudited) | |||||||
| (In thousands, except per share amounts) | |||||||
| Twelve Months Ended | |||||||
| Sales | |||||||
| Domestic sales | $ | 106,123 | $ | 105,745 | |||
| International sales | 144,317 | 158,570 | |||||
| Total sales | 250,440 | 264,315 | |||||
| Cost of goods sold | 167,464 | 171,696 | |||||
| Gross profit | 82,976 | 92,619 | |||||
| Operating expenses | |||||||
| Selling, general and administrative | 105,173 | 111,948 | |||||
| Restructuring charges | 967 | 1,948 | |||||
| Transaction costs | 752 | 576 | |||||
| Contingent consideration benefit | (355 | ) | (125 | ) | |||
| Legal costs and regulatory matter expenses | 4,682 | 3,842 | |||||
| Impairment of goodwill | 3,804 | 36,264 | |||||
| Impairment of indefinite-lived intangible assets | 27,634 | 8,545 | |||||
| Total operating expenses | 142,657 | 162,998 | |||||
| Operating loss | (59,681 | ) | (70,379 | ) | |||
| Other income (expense) | |||||||
| Interest income, net | 619 | 1,467 | |||||
| Other, net | 1,973 | (1,673 | ) | ||||
| Total other income (expense), net | 2,592 | (206 | ) | ||||
| Loss before income tax | (57,089 | ) | (70,585 | ) | |||
| Income tax (benefit) expense | (10,533 | ) | 17,852 | ||||
| Loss from continuing operations | (46,556 | ) | (88,437 | ) | |||
| Discontinued operations, net of tax | - | 36,150 | |||||
| Net loss | $ | (46,556 | ) | $ | (52,287 | ) | |
| Loss from continuing operations per share: | |||||||
| Basic | $ | (1.21 | ) | $ | (2.31 | ) | |
| Diluted | (1.21 | ) | (2.31 | ) | |||
| Net loss per share: | |||||||
| Basic | $ | (1.21 | ) | $ | (1.37 | ) | |
| Diluted | (1.21 | ) | (1.37 | ) | |||
| Weighted average shares outstanding: | |||||||
| Basic | 38,393 | 38,305 | |||||
| Diluted | 38,393 | 38,305 | |||||
| RECONCILIATION FROM GROSS PROFIT TO ADJUSTED GROSS PROFIT | ||||||||||
| AND ADJUSTED GROSS MARGIN | ||||||||||
| THREE MONTHS ENDED | ||||||||||
| Sales | $ | 65,413 | Sales | $ | 71,405 | |||||
| Gross profit as reported | $ | 18,136 | Gross profit as reported | $ | 23,865 | |||||
| Plus impact of inventory fair value adjustment | - | Plus impact of inventory fair value adjustment | 61 | |||||||
| Plus impact of other inventory reserves | 3,840 | Plus impact of PFAS and other inventory reserves | 3,179 | |||||||
| Adjusted gross profit | $ | 21,976 | Adjusted gross profit | $ | 27,105 | |||||
| Gross margin as reported | 27.7 | % | Gross margin as reported | 33.4 | % | |||||
| Adjusted gross margin | 33.6 | % | Adjusted gross margin | 38.0 | % | |||||
| TWELVE MONTHS ENDED | ||||||||||
| Sales | $ | 250,440 | Sales | $ | 264,315 | |||||
| Gross profit as reported | $ | 82,976 | Gross profit as reported | $ | 92,619 | |||||
| Plus impact of inventory fair value adjustment | 120 | Plus impact of inventory fair value adjustment | 61 | |||||||
| Plus impact of other inventory reserves | 4,330 | Plus impact of PFAS and other inventory reserves | 6,502 | |||||||
| Adjusted gross profit | $ | 87,426 | Adjusted gross profit | $ | 99,182 | |||||
| Gross margin as reported | 33.1 | % | Gross margin as reported | 35.0 | % | |||||
| Adjusted gross margin | 34.9 | % | Adjusted gross margin | 37.5 | % | |||||
| RECONCILIATION FROM LOSS FROM CONTINUING OPERATIONS TO ADJUSTED INCOME (LOSS) FROM CONTINUING OPERATIONS AND RELATED EARNINGS PER DILUTED SHARE | |||||||||||||||||||||||||
| (In thousands, except per share amounts) | |||||||||||||||||||||||||
| Three Months Ended | |||||||||||||||||||||||||
| Total | Gross | Operating | Income tax | Tax | (Loss) income from | Diluted | |||||||||||||||||||
| sales | profit | expenses | (benefit) expense | rate | continuing operations | EPS(1) | |||||||||||||||||||
| As reported | $ | 65,413 | $ | 18,136 | $ | 57,128 | $ | (6,656 | ) | (17.6 | ) | % | $ | (31,261 | ) | $ | (0.81 | ) | |||||||
| Amortization of intangibles | - | - | (2,154 | ) | 122 | 2,032 | |||||||||||||||||||
| Impairment of goodwill | - | - | (3,804 | ) | 576 | 3,228 | |||||||||||||||||||
| Impairment of indefinite-lived intangible assets | - | - | (26,069 | ) | 8,181 | 17,888 | |||||||||||||||||||
| Disposal of internally developed software | - | - | (222 | ) | - | 222 | |||||||||||||||||||
| Restructuring charges | - | - | (478 | ) | 55 | 423 | |||||||||||||||||||
| Transaction costs | - | - | (66 | ) | 163 | (97 | ) | ||||||||||||||||||
| Other inventory reserves | - | 3,840 | - | 1,072 | 2,768 | ||||||||||||||||||||
| Legal costs and regulatory matter expenses | - | - | (1,219 | ) | 986 | 233 | |||||||||||||||||||
| Stock-based compensation | - | - | (1,327 | ) | 392 | 935 | |||||||||||||||||||
| Valuation allowance | - | - | - | (7,292 | ) | 7,292 | |||||||||||||||||||
| As adjusted | $ | 65,413 | $ | 21,976 | $ | 21,789 | $ | (2,376 | ) | (188.3 | ) | % | $ | 3,638 | $ | 0.09 | |||||||||
| (1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share is calculated based on 38,402 basic and diluted weighted average shares of common stock. Adjusted income from continuing operations per share is calculated based on 38,452 diluted shares of common stock. | |||||||||||||||||||||||||
| Three Months Ended | |||||||||||||||||||||||||
| Total | Gross | Operating | Income tax | Tax | (Loss) income from | Diluted | |||||||||||||||||||
| sales | profit | expenses | (benefit) expense | rate | continuing operations | EPS(1) | |||||||||||||||||||
| As reported | $ | 71,405 | $ | 23,865 | $ | 73,975 | $ | 21,142 | 40.5 | % | $ | (73,325 | ) | $ | (1.92 | ) | |||||||||
| Amortization of intangibles | - | - | (2,468 | ) | 1,240 | 1,228 | |||||||||||||||||||
| Impairment of goodwill | - | - | (36,264 | ) | - | 36,264 | |||||||||||||||||||
| Impairment of indefinite-lived intangible assets | - | - | (8,545 | ) | 2,564 | 5,981 | |||||||||||||||||||
| Restructuring charges | - | - | (939 | ) | 251 | 688 | |||||||||||||||||||
| Transaction costs | - | - | (408 | ) | 87 | 321 | |||||||||||||||||||
| Inventory fair value of purchase accounting | - | 61 | - | 13 | 48 | ||||||||||||||||||||
| PFAS and other inventory reserves | - | 3,179 | - | 766 | 2,413 | ||||||||||||||||||||
| Legal costs and regulatory matter expenses | - | - | (47 | ) | 23 | 24 | |||||||||||||||||||
| Stock-based compensation | - | - | (1,570 | ) | (588 | ) | 2,158 | ||||||||||||||||||
| Valuation allowance | - | - | - | (21,038 | ) | 21,038 | |||||||||||||||||||
| As adjusted | $ | 71,405 | $ | 27,105 | $ | 23,734 | $ | 4,460 | 343.6 | % | $ | (3,162 | ) | $ | (0.08 | ) | |||||||||
| (1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share and adjusted loss from continuing operations per share are both calculated based on 38,262 basic and diluted weighted average shares of common stock. | |||||||||||||||||||||||||
| RECONCILIATION FROM LOSS FROM CONTINUING OPERATIONS TO ADJUSTED INCOME (LOSS) FROM CONTINUING OPERATIONS AND RELATED EARNINGS PER DILUTED SHARE | |||||||||||||||||||||||||
| (In thousands, except per share amounts) | |||||||||||||||||||||||||
| Twelve Months Ended | |||||||||||||||||||||||||
| Total | Gross | Operating | Income tax | Tax | (Loss) income from | Diluted | |||||||||||||||||||
| sales | profit | expenses | (benefit) expense | rate | continuing operations | EPS(1) | |||||||||||||||||||
| As reported | $ | 250,440 | $ | 82,976 | $ | 142,657 | $ | (10,533 | ) | (18.5 | ) | % | $ | (46,556 | ) | $ | (1.21 | ) | |||||||
| Amortization of intangibles | - | - | (8,740 | ) | 2,385 | 6,355 | |||||||||||||||||||
| Impairment of goodwill | - | - | (3,804 | ) | 576 | 3,228 | |||||||||||||||||||
| Impairment of indefinite-lived intangible assets | - | - | (27,634 | ) | 8,181 | 19,453 | |||||||||||||||||||
| Disposal of internally developed software | - | - | (587 | ) | 177 | 410 | |||||||||||||||||||
| Restructuring charges | - | - | (967 | ) | 241 | 726 | |||||||||||||||||||
| Transaction costs | - | - | (752 | ) | 162 | 590 | |||||||||||||||||||
| Contingent consideration benefit | - | - | 355 | - | (355 | ) | |||||||||||||||||||
| Inventory fair value of purchase accounting | - | 120 | - | 25 | 95 | ||||||||||||||||||||
| Other inventory reserves | - | 4,330 | - | 1,072 | 3,258 | ||||||||||||||||||||
| Legal costs and regulatory matter expenses | - | - | (4,682 | ) | 983 | 3,699 | |||||||||||||||||||
| Stock-based compensation | - | - | (5,895 | ) | 391 | 5,504 | |||||||||||||||||||
| Valuation allowance | - | - | - | (7,292 | ) | 7,292 | |||||||||||||||||||
| As adjusted | $ | 250,440 | $ | 87,426 | $ | 89,951 | $ | (3,632 | ) | (5,420.9 | ) | % | $ | 3,699 | $ | 0.10 | |||||||||
| (1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share is calculated based on 38,393 basic and diluted weighted average shares of common stock. Adjusted income from continuing operations per share is calculated based on 38,443 diluted shares of common stock. | |||||||||||||||||||||||||
| Twelve Months Ended | |||||||||||||||||||||||||
| Total | Gross | Operating | Income tax | Tax | (Loss) income from | Diluted | |||||||||||||||||||
| sales | profit | expenses | (benefit) expense | rate | continuing operations | EPS(1) | |||||||||||||||||||
| As reported | $ | 264,315 | $ | 92,619 | $ | 162,998 | $ | 17,852 | 25.3 | % | $ | (88,437 | ) | $ | (2.31 | ) | |||||||||
| Amortization of intangibles | - | - | (9,784 | ) | 2,751 | 7,033 | |||||||||||||||||||
| Impairment of goodwill | - | - | (36,264 | ) | - | 36,264 | |||||||||||||||||||
| Impairment of indefinite-lived intangible assets | - | - | (8,545 | ) | 2,564 | 5,981 | |||||||||||||||||||
| Restructuring charges | - | - | (1,948 | ) | 459 | 1,489 | |||||||||||||||||||
| Transaction costs | - | - | (576 | ) | 122 | 454 | |||||||||||||||||||
| Contingent consideration benefit | - | - | 125 | (26 | ) | (99 | ) | ||||||||||||||||||
| Inventory fair value of purchase accounting | - | 61 | - | 13 | 48 | ||||||||||||||||||||
| PFAS and other inventory reserves | - | 6,502 | - | 1,453 | 5,049 | ||||||||||||||||||||
| Legal costs and regulatory matter expenses | - | - | (3,842 | ) | 807 | 3,035 | |||||||||||||||||||
| Stock-based compensation | - | - | (5,823 | ) | 291 | 5,532 | |||||||||||||||||||
| Valuation allowance | - | - | - | (21,038 | ) | 21,038 | |||||||||||||||||||
| As adjusted | $ | 264,315 | $ | 99,182 | $ | 96,341 | $ | 5,248 | 199.2 | % | $ | (2,613 | ) | $ | (0.07 | ) | |||||||||
| (1) Potentially dilutive securities are excluded from the computation of diluted earnings (loss) per share if their effect is anti-dilutive to the loss from continuing operations. Reported loss from continuing operations per share and adjusted loss from continuing operations per share are both calculated based on 38,305 basic and diluted weighted average shares of common stock. | |||||||||||||||||||||||||
| RECONCILIATION FROM OPERATING INCOME (LOSS) TO EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA), EBITDA MARGIN, ADJUSTED EBITDA, AND ADJUSTED EBITDA MARGIN | |||||||||||||||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||||||||||||
| Three Months Ended | Three Months Ended | ||||||||||||||||||||||||||||||||
| Outdoor Segment | Adventure Segment | Corporate Costs | Total | Outdoor Segment | Adventure Segment | Corporate Costs | Total | ||||||||||||||||||||||||||
| Operating income (loss) | $ | (553 | ) | $ | (35,485 | ) | $ | (2,954 | ) | $ | (38,992 | ) | $ | 1,897 | $ | (48,582 | ) | $ | (3,425 | ) | $ | (50,110 | ) | ||||||||||
| Depreciation | 587 | 400 | - | 987 | 614 | 369 | - | 983 | |||||||||||||||||||||||||
| Amortization of intangibles | 223 | 1,931 | - | 2,154 | 285 | 2,183 | - | 2,468 | |||||||||||||||||||||||||
| EBITDA | 257 | (33,154 | ) | (2,954 | ) | (35,851 | ) | 2,796 | (46,030 | ) | (3,425 | ) | (46,659 | ) | |||||||||||||||||||
| Restructuring charges | 467 | 11 | - | 478 | 789 | 150 | - | 939 | |||||||||||||||||||||||||
| Transaction costs | 44 | - | 22 | 66 | 65 | 307 | 36 | 408 | |||||||||||||||||||||||||
| Legal costs and regulatory matter expenses | 775 | - | 444 | 1,219 | 10 | - | 37 | 47 | |||||||||||||||||||||||||
| Impairment of goodwill | - | 3,804 | - | 3,804 | - | 36,264 | - | 36,264 | |||||||||||||||||||||||||
| Impairment of indefinite-lived intangible assets | - | 26,069 | - | 26,069 | - | 8,545 | - | 8,545 | |||||||||||||||||||||||||
| Disposal of internally developed software | - | 222 | - | 222 | - | - | - | - | |||||||||||||||||||||||||
| Stock-based compensation | - | - | 1,327 | 1,327 | - | - | 1,570 | 1,570 | |||||||||||||||||||||||||
| Inventory fair value of purchase accounting | - | - | - | - | - | 61 | - | 61 | |||||||||||||||||||||||||
| PFAS and other inventory reserves | 459 | 3,381 | - | 3,840 | 869 | 2,310 | - | 3,179 | |||||||||||||||||||||||||
| Adjusted EBITDA | $ | 2,002 | $ | 333 | $ | (1,161 | ) | $ | 1,174 | $ | 4,529 | $ | 1,607 | $ | (1,782 | ) | $ | 4,354 | |||||||||||||||
| Sales | $ | 47,191 | $ | 18,222 | $ | - | $ | 65,413 | $ | 51,072 | $ | 20,333 | $ | - | $ | 71,405 | |||||||||||||||||
| EBITDA margin | 0.5 | % | (181.9 | ) | % | (54.8 | ) | % | 5.5 | % | (226.4 | ) | % | (65.3 | ) | % | |||||||||||||||||
| Adjusted EBITDA margin | 4.2 | % | 1.8 | % | 1.8 | % | 8.9 | % | 7.9 | % | 6.1 | % | |||||||||||||||||||||
| RECONCILIATION FROM OPERATING LOSS TO EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION, AND AMORTIZATION (EBITDA), EBITDA MARGIN, ADJUSTED EBITDA, AND ADJUSTED EBITDA MARGIN | |||||||||||||||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||||||||||||
| Twelve Months Ended | Twelve Months Ended | ||||||||||||||||||||||||||||||||
| Outdoor Segment | Adventure Segment | Corporate Costs | Total | Outdoor Segment | Adventure Segment | Corporate Costs | Total | ||||||||||||||||||||||||||
| Operating loss | $ | (1,452 | ) | $ | (42,463 | ) | $ | (15,766 | ) | $ | (59,681 | ) | $ | (999 | ) | $ | (53,126 | ) | $ | (16,254 | ) | $ | (70,379 | ) | |||||||||
| Depreciation | 2,177 | 1,464 | - | 3,641 | 2,588 | 1,446 | - | 4,034 | |||||||||||||||||||||||||
| Amortization of intangibles | 973 | 7,767 | - | 8,740 | 1,142 | 8,642 | - | 9,784 | |||||||||||||||||||||||||
| EBITDA | 1,698 | (33,232 | ) | (15,766 | ) | (47,300 | ) | 2,731 | (43,038 | ) | (16,254 | ) | (56,561 | ) | |||||||||||||||||||
| Restructuring charges | 599 | 368 | - | 967 | 1,349 | 599 | - | 1,948 | |||||||||||||||||||||||||
| Transaction costs | 614 | 40 | 98 | 752 | 65 | 396 | 115 | 576 | |||||||||||||||||||||||||
| Contingent consideration benefit | - | (355 | ) | - | (355 | ) | - | (125 | ) | - | (125 | ) | |||||||||||||||||||||
| Legal costs and regulatory matter expenses | 2,825 | - | 1,857 | 4,682 | 3,088 | - | 754 | 3,842 | |||||||||||||||||||||||||
| Impairment of goodwill | - | 3,804 | - | 3,804 | - | 36,264 | - | 36,264 | |||||||||||||||||||||||||
| Impairment of indefinite-lived intangible assets | 1,565 | 26,069 | - | 27,634 | - | 8,545 | - | 8,545 | |||||||||||||||||||||||||
| Disposal of internally developed software | - | 587 | - | 587 | - | - | - | - | |||||||||||||||||||||||||
| Stock-based compensation | - | - | 5,895 | 5,895 | - | - | 5,823 | 5,823 | |||||||||||||||||||||||||
| Inventory fair value of purchase accounting | - | 120 | - | 120 | - | 61 | - | 61 | |||||||||||||||||||||||||
| PFAS and other inventory reserves | 949 | 3,381 | - | 4,330 | 4,192 | 2,310 | - | 6,502 | |||||||||||||||||||||||||
| Adjusted EBITDA | $ | 8,250 | $ | 782 | $ | (7,916 | ) | $ | 1,116 | $ | 11,425 | $ | 5,012 | $ | (9,562 | ) | $ | 6,875 | |||||||||||||||
| Sales | $ | 176,863 | $ | 73,577 | $ | - | $ | 250,440 | $ | 183,568 | $ | 80,747 | $ | - | $ | 264,315 | |||||||||||||||||
| EBITDA margin | 1.0 | % | (45.2 | ) | % | (18.9 | ) | % | 1.5 | % | (53.3 | ) | % | (21.4 | ) | % | |||||||||||||||||
| Adjusted EBITDA margin | 4.7 | % | 1.1 | % | 0.4 | % | 6.2 | % | 6.2 | % | 2.6 | % | |||||||||||||||||||||
Source: 